Inventor · disambiguated record
Jason M. Cox
Also filed as: COX JASON · COX JASON M · COX JASON MICHAEL
33 granted patents·16 pending applications·64 citations·filing 2005–2025
95Inventor score
Files withMERCK SHARP & DOHME19KINNATE BIOPHARMA INC13MERCK SHARP & DOHME LLC7BIFTU TESFAYE2COX JASON M2
Top patents by PatentIndex Score
49 records- 0196US11407737B2Inhibitors of RAF kinasesKINNATE BIOPHARMA INC·Filed 2021·Granted Aug 9, 2022·8 cites·30 claims
- 0295US11377431B2Inhibitors of RAF kinasesKINNATE BIOPHARMA INC·Filed 2021·Granted Jul 5, 2022·7 cites·30 claims
- 0395US11345681B1Inhibitors of fibroblast growth factor receptor kinasesKINNATE BIOPHARMA INC·Filed 2021·Granted May 31, 2022·4 cites·19 claims
- 0494US11780862B2Inhibitors of MEK kinaseKINNATE BIOPHARMA INC·Filed 2023·Granted Oct 10, 2023·2 cites·27 claims
- 0591US11377438B22-amino-n-heteroaryl-nicotinamides as Nav1.8 inhibitorsMERCK SHARP & DOHME·Filed 2019·Granted Jul 5, 2022·6 cites·22 claims
- 0691US8143289B2Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetesBIFTU TESFAYE·Filed 2009·Granted Mar 27, 2012·12 cites·25 claims
- 0789US11753395B2Inhibitors of MET kinaseKINNATE BIOPHARMA INC·Filed 2022·Granted Sep 12, 2023·1 cites·30 claims
- 0889US11746095B2Inhibtors of RAF kinasesKINNATE BIOPHARMA INC·Filed 2022·Granted Sep 5, 2023·1 cites·10 claims
- 0984US7750034B2Aminocyclohexanes as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetesMERCK SHARP & DOHME·Filed 2007·Granted Jul 6, 2010·8 cites·13 claims
- 1083US2025250293A1Inhibitors of mek kinaseMOSAICA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1182US12122800B2Inhibitors of MEK kinaseKINNATE BIOPHARMA INC·Filed 2023·Granted Oct 22, 2024·0 cites·16 claims
- 1281US11028092B2Substituted pyrazolo[3,4-d]pyrimidines as PDE9 inhibitorsMERCK SHARP & DOHME·Filed 2019·Granted Jun 8, 2021·2 cites·24 claims
- 1380US2025084064A12-amino-n-heteroaryl-nicotinamides as nav1.8 inhibitorsMERCK SHARP & DOHME LLC·Filed 2024·Application pending·0 cites
- 1479US8653059B2Heterocyclic compounds as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetesBIFTU TESFAYE·Filed 2008·Granted Feb 18, 2014·4 cites·29 claims
- 1578US10934294B2Substituted pyrazolo[3,4-d]pyrimidines as PDE9 inhibitorsMERCK SHARP & DOHME·Filed 2018·Granted Mar 2, 2021·2 cites·13 claims
- 1678US7884104B2Aminopiperidines as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetesMERCK SHARP & DOHME·Filed 2005·Granted Feb 8, 2011·4 cites·15 claims
- 1777US7718667B2Fused aminopiperidines as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetesMERCK SHARP & DOHME·Filed 2005·Granted May 18, 2010·2 cites·13 claims
- 1873US11814384B2Inhibtors of Raf kinasesKINNATE BIOPHARMA INC·Filed 2023·Granted Nov 14, 2023·0 cites·30 claims
- 1972US12195445B22-amino-N-heteroaryl-nicotinamides as Nav1.8 inhibitorsMERCK SHARP & DOHME LLC·Filed 2022·Granted Jan 14, 2025·0 cites·15 claims
- 2071US7910596B2Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetesMERCK SHARP & DOHME·Filed 2007·Granted Mar 22, 2011·1 cites·11 claims
- 2171US2024182467A1Inhibitors of raf kinasesKINNATE BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 2270US2023312528A12-oxo-imidazolidine-4-carboxamides as nav1.8 inhibitorsMERCK SHARP & DOHME LLC·Filed 2023·Application pending·0 cites
- 2369US2025333399A1Inhibitors of fibroblast growth factor receptor kinasesKHORA SPV 1 LLC·Filed 2025·Application pending·0 cites
- 2466US12331039B2Inhibitors of fibroblast growth factor receptor kinasesKHORA SPV 1 LLC·Filed 2022·Granted Jun 17, 2025·0 cites·14 claims
- 2566US2022340543A1Inhibitors of raf kinasesKINNATE BIOPHARMA INC·Filed 2022·Application pending·0 cites
- 2662US11802122B22-oxoimidazolidine-4-carboxamides as NAv1.8 inhibitorsMERCK SHARP & DOHME·Filed 2021·Granted Oct 31, 2023·0 cites·46 claims
- 2762US11161819B2Substituted tetrahydroisoquinoline compounds useful as GPR120 agonistsMERCK SHARP & DOHME·Filed 2020·Granted Nov 2, 2021·0 cites·17 claims
- 2861US2025163063A1Inhibitors of cdk4/6 kinaseKINNATE BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 2960US2025059170A1Solid state forms of an fgfr inhibitorKINNATE BIOPHARMA INC·Filed 2022·Application pending·0 cites
- 3058US2019307735A1Composition and Methods for Treating Chronic Kidney DiseaseMERCK SHARP & DOHME·Filed 2019·Application pending·0 cites
- 3156US2022380338A1Cycloalkyl 3-oxopiperazine carboxamides and cycloheteroalkyl 3-oxopiperazine carboxamides as nav1.8 inhibitorsMERCK SHARP & DOHME LLC·Filed 2022·Application pending·0 cites
- 3256US2024246932A1Aryl 3-oxopiperazine carboxamides and heteroaryl 3-oxopiperazine carboxamides as nav1.8 inhibitorsMERCK SHARP & DOHME LLC·Filed 2022·Application pending·0 cites
- 3355US2025032458A1Treatment of cancer with an fgfr kinase inhibitorKINNATE BIOPHARMA INC·Filed 2022·Application pending·0 cites
- 3454US2019161448A1Substituted tetrahydroisoquinoline compounds useful as gpr120 agonistsMERCK SHARP & DOHME·Filed 2017·Application pending·0 cites
- 3554US2022017526A1Pyrazolopyrimidine pde9 inhibitorsMERCK SHARP & DOHME·Filed 2019·Application pending·0 cites
- 3653US12246008B24-amino or 4-alkoxy-substituted aryl sulfonamide compounds with selective activity in voltage-gated sodium channelsMERCK SHARP & DOHME LLC·Filed 2019·Granted Mar 11, 2025·0 cites·17 claims
- 3749US2023227405A15-oxopyrrolidine-3-carboxamides as nav1.8 inhibitorsARASAPPAN ASHOK·Filed 2021·Application pending·0 cites
- 3848US7855206B2Tricyclic heteroaromatic compounds as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetesMERCK SHARP & DOHME·Filed 2007·Granted Dec 21, 2010·0 cites·18 claims
- 3947US12247031B2Cyclobutyl pyrazolopyrimidine PDE9 inhibitorsMERCK SHARP & DOHME LLC·Filed 2019·Granted Mar 11, 2025·0 cites·5 claims
- 4045US8017624B2Fused aminopiperidines as dipeptidyi peptidase-IV inhibitors for the treatment or prevention of diabetesMERCK SHARP & DOHME·Filed 2006·Granted Sep 13, 2011·0 cites·17 claims
- 4145US7943615B2Fused aminopiperidines as dipeptidyl peptidase-4 inhibitors for the treatment or prevention of diabetesMERCK SHARP & DOHME·Filed 2006·Granted May 17, 2011·0 cites·8 claims
- 4245US7906649B2Aminocyclohexanes as dipeptidyl peptidase-IV inhibitors for the treatment of diabetesMERCK SHARP & DOHME·Filed 2006·Granted Mar 15, 2011·0 cites·15 claims
- 4344US9505730B2Mineralocorticoid receptor antagonistsSHEN HONG·Filed 2012·Granted Nov 29, 2016·0 cites·9 claims
- 4442US10864211B2Hydroxy isoxazole compounds useful as GPR120 agonistsMERCK SHARP & DOHME·Filed 2017·Granted Dec 15, 2020·0 cites·14 claims
- 4542US9708270B2Substituted spiropiperidinyl compounds useful as GPR120 agonistsMERCK SHARP & DOHME·Filed 2013·Granted Jul 18, 2017·0 cites·10 claims
- 4640US9193717B2Mineralocorticoid receptor antagonistsSHEN HONG·Filed 2012·Granted Nov 24, 2015·0 cites·12 claims
- 4740US9085568B2Mineralocorticoid receptor antagonistsMERCK SHARP & DOHME·Filed 2012·Granted Jul 21, 2015·0 cites·13 claims
- 4840US2018110762A1Compositions Methods for Treating Chronic Kidney DiseaseCOX JASON M·Filed 2016·Application pending·0 cites
- 4928US8716482B2Substituted aminopiperidines as dipeptidyl peptidase-IV inhibitors for the treatment of diabetesCOX JASON M·Filed 2010·Granted May 6, 2014·0 cites·23 claims
Join the waitlist — get patent alerts
Get an alert when Jason M. Cox files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →